Regulation of Absorption and ABC1-Mediated Efflux of Cholesterol by RXR Heterodimers

Joyce J. Repa(Howard Hughes Medical Institute), S D Turley(The University of Texas Southwestern Medical Center), Jean Marc Lobaccaro(Howard Hughes Medical Institute), Julio C. Medina(TiVo (United States)), L. Li(TiVo (United States)), Kevin D. Lustig(TiVo (United States)), B Shan(TiVo (United States)), Richard A. Heyman(Ligand Pharmaceuticals (United States)), John M. Dietschy(The University of Texas Southwestern Medical Center), David J. Mangelsdorf(Howard Hughes Medical Institute)
Science
September 1, 2000
Cited by 1,298

Abstract

Several nuclear hormone receptors involved in lipid metabolism form obligate heterodimers with retinoid X receptors (RXRs) and are activated by RXR agonists such as rexinoids. Animals treated with rexinoids exhibited marked changes in cholesterol balance, including inhibition of cholesterol absorption and repressed bile acid synthesis. Studies with receptor-selective agonists revealed that oxysterol receptors (LXRs) and the bile acid receptor (FXR) are the RXR heterodimeric partners that mediate these effects by regulating expression of the reverse cholesterol transporter, ABC1, and the rate-limiting enzyme of bile acid synthesis, CYP7A1, respectively. Thus, these RXR heterodimers serve as key regulators of cholesterol homeostasis by governing reverse cholesterol transport from peripheral tissues, bile acid synthesis in liver, and cholesterol absorption in intestine.


Related Papers

No related papers found

Powered by citation graph analysis